ID   LMTK1_HUMAN             Reviewed;        1374 AA.
AC   Q6ZMQ8; O75136; Q6ZN31; Q86X28;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 2.
DT   05-OCT-2010, entry version 67.
DE   RecName: Full=Serine/threonine-protein kinase LMTK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Apoptosis-associated tyrosine kinase;
DE            Short=AATYK;
DE   AltName: Full=Brain apoptosis-associated tyrosine kinase;
DE   AltName: Full=CDK5-binding protein;
DE   AltName: Full=Lemur tyrosine kinase 1;
DE   AltName: Full=p35-binding protein;
DE            Short=p35BP;
GN   Name=AATK; Synonyms=AATYK, KIAA0641, LMR1, LMTK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   CYS-703.
RC   TISSUE=Cerebellum, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 49-1374 (ISOFORM 1), AND
RP   VARIANT CYS-703.
RC   TISSUE=Brain;
RX   MEDLINE=98403880; PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 786-1374 (ISOFORM 1), AND
RP   VARIANT SER-1266.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ALTERNATIVE SPLICING (ISOFORM 2), INTERACTION WITH CDK5, AND
RP   PHOSPHORYLATION.
RX   PubMed=14521924; DOI=10.1016/j.bbrc.2003.08.143;
RA   Honma N., Asada A., Takeshita S., Enomoto M., Yamakawa E.,
RA   Tsutsumi K., Saito T., Satoh T., Itoh H., Kaziro Y., Kishimoto T.,
RA   Hisanaga S.;
RT   "Apoptosis-associated tyrosine kinase is a Cdk5 activator p35 binding
RT   protein.";
RL   Biochem. Biophys. Res. Commun. 310:398-404(2003).
RN   [6]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=10837911; DOI=10.1016/S0169-328X(00)00048-6;
RA   Raghunath M., Patti R., Bannerman P., Lee C.M., Baker S., Sutton L.N.,
RA   Phillips P.C., Damodar Reddy C.;
RT   "A novel kinase, AATYK induces and promotes neuronal differentiation
RT   in a human neuroblastoma (SH-SY5Y) cell line.";
RL   Brain Res. Mol. Brain Res. 77:151-162(2000).
RN   [7]
RP   VARIANTS PHE-81; VAL-97; VAL-104; CYS-703; ARG-815; LEU-923; LYS-1160;
RP   SER-1192; SER-1266 AND THR-1332.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be involved in neuronal differentiation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with CDK5.
CC   -!- INTERACTION:
CC       Q00535:CDK5; NbExp=2; IntAct=EBI-2008380, EBI-1041567;
CC       Q15078:CDK5R1; NbExp=4; IntAct=EBI-2008380, EBI-746189;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein (By similarity). Cytoplasm. Cytoplasm, perinuclear region.
CC       Note=Predominantly perinuclear.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZMQ8-1; Sequence=Displayed;
CC       Name=2; Synonyms=hAATYKs-p35BP;
CC         IsoId=Q6ZMQ8-2; Sequence=VSP_020225, VSP_020226, VSP_020227,
CC                                  VSP_020228;
CC       Name=3;
CC         IsoId=Q6ZMQ8-3; Sequence=VSP_020226, VSP_020227, VSP_020228;
CC   -!- TISSUE SPECIFICITY: Expressed in brain.
CC   -!- INDUCTION: Up-regulated during apoptosis.
CC   -!- PTM: Autophosphorylated. Phosphorylated by CDK5.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=CGP resequencing studies;
CC       URL="http://www.sanger.ac.uk/perl/genetics/CGP/cgp_viewer?action=gene&ln=AATK";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK131395; BAD18544.1; -; mRNA.
DR   EMBL; AK131529; BAD18667.1; -; mRNA.
DR   EMBL; AB014541; BAA31616.2; -; mRNA.
DR   EMBL; BC047378; AAH47378.1; -; mRNA.
DR   IPI; IPI00784827; -.
DR   IPI; IPI00797912; -.
DR   IPI; IPI00883789; -.
DR   RefSeq; NP_001073864.2; -.
DR   UniGene; Hs.514575; -.
DR   HSSP; P08069; 1JQH.
DR   ProteinModelPortal; Q6ZMQ8; -.
DR   SMR; Q6ZMQ8; 119-398.
DR   IntAct; Q6ZMQ8; 25.
DR   STRING; Q6ZMQ8; -.
DR   PhosphoSite; Q6ZMQ8; -.
DR   Ensembl; ENST00000326724; ENSP00000324196; ENSG00000181409.
DR   GeneID; 9625; -.
DR   KEGG; hsa:9625; -.
DR   UCSC; uc010dia.1; human.
DR   CTD; 9625; -.
DR   GeneCards; GC17M079091; -.
DR   H-InvDB; HIX0023268; -.
DR   HGNC; HGNC:21; AATK.
DR   HPA; HPA009073; -.
DR   MIM; 605276; gene.
DR   PharmGKB; PA24370; -.
DR   eggNOG; prNOG10948; -.
DR   HOGENOM; HBG715274; -.
DR   HOVERGEN; HBG080533; -.
DR   InParanoid; Q6ZMQ8; -.
DR   OMA; ESQSARN; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 36117; -.
DR   ArrayExpress; Q6ZMQ8; -.
DR   Bgee; Q6ZMQ8; -.
DR   CleanEx; HS_AATK; -.
DR   Genevestigator; Q6ZMQ8; -.
DR   GermOnline; ENSG00000181409; Homo sapiens.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020737; Ser/Thr_kinase_rcpt_LMTK.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   PANTHER; PTHR23256:SF248; Ser/Thr_kinase_rcpt_LMTK; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1   1374       Serine/threonine-protein kinase LMTK1.
FT                                /FTId=PRO_0000248300.
FT   TRANSMEM     32     52       Helical; (Potential).
FT   DOMAIN      125    395       Protein kinase.
FT   NP_BIND     131    139       ATP (By similarity).
FT   COMPBIAS    420    429       Poly-Gly.
FT   COMPBIAS    709    829       Pro-rich.
FT   COMPBIAS    847    850       Poly-Ser.
FT   COMPBIAS   1052   1151       Pro-rich.
FT   COMPBIAS   1159   1163       Poly-Glu.
FT   ACT_SITE    253    253       Proton acceptor (By similarity).
FT   BINDING     156    156       ATP (By similarity).
FT   VAR_SEQ       1    433       Missing (in isoform 2).
FT                                /FTId=VSP_020225.
FT   VAR_SEQ     468    503       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_020226.
FT   VAR_SEQ     897    915       VGTPDSLDSLDIPSSASDG -> WPQREESLPRLCLLLRPR
FT                                G (in isoform 2 and isoform 3).
FT                                /FTId=VSP_020227.
FT   VAR_SEQ     916   1374       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_020228.
FT   VARIANT      81     81       S -> F (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_032679.
FT   VARIANT      97     97       L -> V (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_032680.
FT   VARIANT     104    104       M -> V (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_032681.
FT   VARIANT     118    118       T -> M (in dbSNP:rs8082016).
FT                                /FTId=VAR_027267.
FT   VARIANT     703    703       G -> C (in dbSNP:rs7503604).
FT                                /FTId=VAR_032682.
FT   VARIANT     815    815       S -> R (in dbSNP:rs56032966).
FT                                /FTId=VAR_032683.
FT   VARIANT     923    923       S -> L (in dbSNP:rs56313973).
FT                                /FTId=VAR_032684.
FT   VARIANT    1160   1160       E -> K (in dbSNP:rs55793641).
FT                                /FTId=VAR_032685.
FT   VARIANT    1192   1192       P -> S (in dbSNP:rs55856613).
FT                                /FTId=VAR_032686.
FT   VARIANT    1266   1266       F -> S (in dbSNP:rs36000545).
FT                                /FTId=VAR_032687.
FT   VARIANT    1332   1332       A -> T (in dbSNP:rs55713566).
FT                                /FTId=VAR_032688.
FT   CONFLICT     49     63       MLACLCCKKGGIGFK -> HQVKVQGCWGRWRWQ (in
FT                                Ref. 2).
FT   CONFLICT    511    511       A -> T (in Ref. 1; BAD18667).
FT   CONFLICT    541    541       A -> T (in Ref. 1; BAD18544).
FT   CONFLICT    557    557       T -> I (in Ref. 1; BAD18544).
FT   CONFLICT    786    786       A -> V (in Ref. 4; AAH47378).
FT   CONFLICT    790    790       T -> A (in Ref. 1; BAD18667).
FT   CONFLICT   1028   1028       P -> R (in Ref. 4; AAH47378).
FT   CONFLICT   1271   1271       P -> H (in Ref. 4; AAH47378).
FT   CONFLICT   1324   1324       P -> R (in Ref. 4; AAH47378).
FT   CONFLICT   1360   1360       K -> E (in Ref. 4; AAH47378).
SQ   SEQUENCE   1374 AA;  144569 MW;  AD46BD688AF7103E CRC64;
     MSSSFFNPSF AFSSHFDPDG APLSELSWPS SLAVVAVSFS GLFAVIVLML ACLCCKKGGI
     GFKEFENAEG DEYAADLAQG SPATAAQNGP DVYVLPLTEV SLPMAKQPGR SVQLLKSTDV
     GRHSLLYLKE IGRGWFGKVF LGEVNSGISS AQVVVKELQA SASVQEQMQF LEEVQPYRAL
     KHSNLLQCLA QCAEVTPYLL VMEFCPLGDL KGYLRSCRVA ESMAPDPRTL QRMACEVACG
     VLHLHRNNFV HSDLALRNCL LTADLTVKIG DYGLAHCKYR EDYFVTADQL WVPLRWIAPE
     LVDEVHSNLL VVDQTKSGNV WSLGVTIWEL FELGTQPYPQ HSDQQVLAYT VREQQLKLPK
     PQLQLTLSDR WYEVMQFCWL QPEQRPTAEE VHLLLSYLCA KGATEAEEEF ERRWRSLRPG
     GGGVGPGPGA AGPMLGGVVE LAAASSFPLL EQFAGDGFHA DGDDVLTVTE TSRGLNFEYK
     WEAGRGAEAF PATLSPGRTA RLQELCAPDG APPGVVPVLS AHSPSLGSEY FIRLEEAAPA
     AGHDPDCAGC APSPPATADQ DDDSDGSTAA SLAMEPLLGH GPPVDVPWGR GDHYPRRSLA
     RDPLCPSRSP SPSAGPLSLA EGGAEDADWG VAAFCPAFFE DPLGTSPLGS SGAPPLPLTG
     EDELEEVGAR RAAQRGHWRS NVSANNNSGS RCPESWDPVS AGGHAEGCPS PKQTPRASPE
     PGYPGEPLLG LQAASAQEPG CCPGLPHLCS AQGLAPAPCL VTPSWTETAS SGGDHPQAEP
     KLATEAEGTT GPRLPLPSVP SPSQEGAPLP SEEASAPDAP DALPDSPTPA TGGEVSAIKL
     ASALNGSSSS PEVEAPSSED EDTAEATSGI FTDTSSDGLQ ARRPDVVPAF RSLQKQVGTP
     DSLDSLDIPS SASDGGYEVF SPSATGPSGG QPRALDSGYD TENYESPEFV LKEAQEGCEP
     QAFAELASEG EGPGPETRLS TSLSGLNEKN PYRDSAYFSD LEAEAEATSG PEKKCGGDRA
     PGPELGLPST GQPSEQVCLR PGVSGEAQGS GPGEVLPPLL QLEGSSPEPS TCPSGLVPEP
     PEPQGPAKVR PGPSPSCSQF FLLTPVPLRS EGNSSEFQGP PGLLSGPAPQ KRMGGPGTPR
     APLRLALPGL PAALEGRPEE EEEDSEDSDE SDEELRCYSV QEPSEDSEEE APAVPVVVAE
     SQSARNLRSL LKMPSLLSET FCEDLERKKK AVSFFDDVTV YLFDQESPTR ELGEPFPGAK
     ESPPTFLRGS PGSPSAPNRP QQADGSPNGS TAEEGGGFAW DDDFPLMTAK AAFAMALDPA
     APAPAAPTPT PAPFSRFTVS PAPTSRFSIT HVSDSDAESK RGPEAGAGGE SKEA
//
